• linkedin
  • Increase Font
  • Sharebar

    How will the ProtecT study affect your care of PCa patients?

    Urology Times reached out to three urologists (selected randomly) and asked them each the following question: How will the ProtecT study affect your care of PCa patients?


    “I’ve introduced a lot of people into active surveillance. They have to meet certain criteria. They have to be followed very carefully. Ten to twenty percent of those people will progress unexpectedly and have a less than favorable outcome, but that’s not going to change how I practice.      

    If they meet the criteria for active surveillance, I actively try to persuade them to do that. If they don’t feel comfortable, obviously I offer robotic prostatectomy or radiation therapy.

    I would say two-thirds of men are willing to try active surveillance, but at least a third are not comfortable; they just want the cancer out. They don’t want to have to come back for a PSA three or four times a year and repeat biopsies every 1 to 2 years. There is a commitment that goes into that. When you look at robotic prostatectomy or brachytherapy, they’re both relatively easy treatments to go through with good results. Particularly younger guys may not want to do active surveillance. There’s some logic to that because eventually in 10, 20 years, they are likely to progress and need treatment later anyway.”

    Gregory McCoy, MD

    Portland, OR

    Next: "You have to understand where the man’s anxiety level is"

    Karen Nash
    Karen Nash is a medical reporter and media consultant based in Monroeville, PA.


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available